US: ACNNF - AusCann Group Holdings Ltd

六个月盈利: +26.67%

促销时间表 AusCann Group Holdings Ltd


关于公司

AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians.

更多详情
AusCann Group Holdings Ltd is based in West Perth, Australia.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://auscann.com.au
Цена ао 0.0038
每日价格变化: 0% (0.0038)
每周价格变化: -38.71% (0.0062)
每月价格变化: -72.06% (0.0136)
3个月内价格变化: -69.6% (0.0125)
六个月内的价格变化: +26.67% (0.003)
每年价格变化: +22.58% (0.0031)
3年内价格变化: -95.03% (0.0765)
5年内价格变化: -98.54% (0.26)
年初以来价格变化: +137.5% (0.0016)

低估

姓名 意义 年级
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % 0 0
ROE, % 0 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 1.42

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 131.31 10
盈利能力 Ebitda, % 129.35 10
盈利能力 EPS, % 627.27 10
全部的: 7.2

导师 职称 支付 出生年份
Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A. Chief Financial Officer
Ms. Rachel Jelleff Kerr Company Secretary

地址: Australia, West Perth, 1202 Hay Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://auscann.com.au